TWi Pharmaceuticals, Inc. drugs

11 results
  • cyclobenzaprine hydrochloride - cyclobenzaprine hydrochloride capsule, extended release

    (Cyclobenzaprine Hydrochloride)
    Twi Pharmaceuticals, Inc.
  • forfivo

    (bupropion hydrochloride)
    TWi Pharmaceuticals, Inc.
    FORFIVO XL (bupropion hydrochloride extended-release) is indicated for the treatment of major depressive disorder (MDD) in adults, as defined by the DSM. Its efficacy is supported by controlled trials for both acute and maintenance treatment of MDD. Regular reevaluation of long-term use is recommended.
  • megestrol acetate

    (Megestrol Acetate)
    TWi Pharmaceuticals, Inc.
    Megestrol acetate oral suspension is indicated for treating anorexia, cachexia, or significant weight loss in AIDS patients. It should be used after identifying and addressing treatable causes of weight loss and is not intended for prophylactic use.
  • naproxen sodium

    (Naproxen Sodium)
    TWi Pharmaceuticals, Inc.
    Naproxen Sodium Controlled-Release Tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for alleviating mild to moderate pain.
  • tadalafil

    (Tadalafil)
    TWi Pharmaceuticals, Inc.
    Tadalafil Tablets are indicated for treating erectile dysfunction (ED), benign prostatic hyperplasia (BPH), and the combined condition of ED and BPH. Use with finasteride for BPH is recommended for up to 26 weeks due to decreasing benefits over time.